title: Hypofractionated radiotherapy in prostate cancer.
abstract: In regards to prostate cancer, the classic radiotherapy dose ranges from 70-80 Gy, administered in daily 2-Gy fractions. However, when taking into account the particular radiobiological model of prostate cancer cells, one realizes that there is a potential theoretical advantage to delivering a greater biological effective dose per treatment in a lower number of fractions. Both recent and older publications have attempted to explore this treatment option. This critical review comprehensively examines the current state of knowledge concerning hypofractionated radiotherapy in prostate cancer.
authors: Department of Radiation Oncology, Hôpital Maisonneuve-Rosemont, 5415 Boulevard de l'Assomption, Montréal, QC H1T 2M4, Canada.
authors: Peter
authors: P
authors: Vavassis
authors: David H A
authors: DH
authors: Nguyen
authors: Jean-Paul
authors: JP
authors: Bahary
authors: Michael
authors: M
authors: Yassa
mesh_terms: D002986:Clinical Trials as Topic; D019583:Dose Fractionation, Radiation; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000532:radiotherapy*; D016896:Treatment Outcome